Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Kalatu Davies"'
Autor:
C. Lance Cowey, Nicholas J. Robert, Janet L. Espirito, Kalatu Davies, Jennifer Frytak, Israel Lowy, Matthew G. Fury
Publikováno v:
Cancer Medicine, Vol 9, Iss 20, Pp 7381-7387 (2020)
Abstract Prior studies of conventional chemotherapy or epidermal growth factor receptor inhibitors for advanced (ie, locally advanced cutaneous squamous cell carcinoma [laCSCC] or metastatic [mCSCC]) cutaneous squamous cell cancer enrolled ≤ 40 pat
Externí odkaz:
https://doaj.org/article/16fe8240e8cf433a9412df569003e488
Autor:
Srinivas Annavarapu, Anagha Gogate, Trang Pham, Kalatu Davies, Prianka Singh, Nicholas Robert
Publikováno v:
CNS Oncology, Vol 10, Iss 3 (2021)
Aim: Investigate real-world outcomes and healthcare utilization of patients with glioblastoma multiforme (GBM) related to O6-methylguanine DNA methyltransferase (MGMT) promoter testing and methylation. Patients & methods: US Oncology Network data wer
Externí odkaz:
https://doaj.org/article/104cfd53b612439a8957ffc5d27e0163
Publikováno v:
Journal of the National Comprehensive Cancer Network. 21:HSR23-118
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ecb62979331472d18c684e08244e05d2
https://doi.org/10.6004/jnccn.2022.7217
https://doi.org/10.6004/jnccn.2022.7217
Autor:
George R. Thompson, Marisa H. Miceli, Jeanette Jiang, Emily F. Shortridge, Kalatu Davies, Giridharan Gurumoorthy, Tomomi Kimura
Publikováno v:
Mycoses. 66:527-539
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa6bfec6f1cc65667caa1b5a69c263ec
https://doi.org/10.1111/myc.13579
https://doi.org/10.1111/myc.13579
Autor:
Lance Cowey, Chieh-I. Chen, Kathleen M. Aguilar, Kalatu Davies, Patrick R. LaFontaine, Matthew G. Fury, Timothy Bowler, Asieh Golozar, Jessica J. Jalbert
Publikováno v:
Dermatology and therapy. 12(5)
Until recently, patients discontinuing first-line (1L) hedgehog inhibitors (HHIs) for basal cell carcinoma (BCC) had few subsequent treatment options. The objective of this study was to describe the treatment journey and prognosis of patients discont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bb490211564e01fe5be164de825768a
https://pubmed.ncbi.nlm.nih.gov/35507216
https://pubmed.ncbi.nlm.nih.gov/35507216
Autor:
Kalatu Davies, Trang Pham, Nicholas J. Robert, Anagha Gogate, Prianka Singh, Srinivas Annavarapu
Publikováno v:
CNS Oncology
Aim: Investigate real-world outcomes and healthcare utilization of patients with glioblastoma multiforme (GBM) related to O6-methylguanine DNA methyltransferase (MGMT) promoter testing and methylation. Patients & methods: US Oncology Network data wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c489e26d09dd8065b87099276b4d94e4
https://pubmed.ncbi.nlm.nih.gov/34378977
https://pubmed.ncbi.nlm.nih.gov/34378977
Autor:
Kalatu Davies, Isabelle Bedrosian, Robert J. Volk, Scott B. Cantor, S Garrison, Patricia A. Parker, Abenaa M. Brewster
Publikováno v:
Cancer Research. 79:P6-11
Background: The majority of women undergoing contralateral prophylactic mastectomy (CPM) overestimate their risk of developing a contralateral breast cancer and incorrectly believe the CPM will substantially improve their overall survival. Using the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f86928ee0b12b8d7b1bdd50fc4e38a1d
https://doi.org/10.1158/1538-7445.sabcs18-p6-11-01
https://doi.org/10.1158/1538-7445.sabcs18-p6-11-01
Autor:
Kat Aguilar, Nicholas J. Robert, Jennifer Frytak, Brigham Walker, Kalatu Davies, Janet L. Espirito, Marley Boyd
Publikováno v:
JCO Clinical Cancer Informatics. :45-46
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36f9dc2e327eac54b9297d63b13c5ea1
https://doi.org/10.1200/cci.20.00125
https://doi.org/10.1200/cci.20.00125
Autor:
Hicham Skali, David Walker, Jeanette Jiang, Giridharan Gurumoorthy, Kalatu Davies, Tomomi Kimura
Publikováno v:
Journal of the American College of Cardiology. 79:2095
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ad1c6070c9fb19b404f7e2befefca14
https://doi.org/10.1016/s0735-1097(22)03086-8
https://doi.org/10.1016/s0735-1097(22)03086-8
Autor:
Nicholas J. Robert, Petros Grivas, Kathleen M. Aguilar, Kalatu Davies, Mark D. Fleming, Brian S. Seal
Publikováno v:
Journal of Clinical Oncology. 39:293-293
293 Background: ICI approval provided new treatment options for patients (pts) with u/mUC. We aimed to assess the adoption of ICI and describe 1L treatment patterns in the US community oncology setting. We hypothesized that most pts would receive ICI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5bb582f939bc6d2792214bff2bb002d9
https://doi.org/10.1200/jco.2020.39.28_suppl.293
https://doi.org/10.1200/jco.2020.39.28_suppl.293